Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer.

about

The Androgen Receptor in Breast Cancer The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology

P2860

Q57107469-4590D04C-A101-4025-8BBA-9F7D8EFD577E Q58707374-0528934E-A8FD-4FC4-A860-5C227523BDA6

P2860

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer.

Item

http://www.wikidata.org/entity/Q46228471

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer.

@en

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer.

@nl

type

Item

label

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer.

@en

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer.

@nl

prefLabel

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer.

@en

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer.

@nl

P1476

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer.

@en

P2093

Guorong Chen

http://www.w3.org/2001/XMLSchema#string

Haihua Gu

http://www.w3.org/2001/XMLSchema#string

Hongwei Gao

http://www.w3.org/2001/XMLSchema#string

Hongzhi Li

http://www.w3.org/2001/XMLSchema#string

Hua Ma

http://www.w3.org/2001/XMLSchema#string

Jennifer K Richer

http://www.w3.org/2001/XMLSchema#string

Jiawei Cao

http://www.w3.org/2001/XMLSchema#string

Kaiyan Yang

http://www.w3.org/2001/XMLSchema#string

Licai He

http://www.w3.org/2001/XMLSchema#string

Tong Li

http://www.w3.org/2001/XMLSchema#string

P2860

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide

Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members

Targeting androgen receptor in estrogen receptor-negative breast cancer

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

Untangling the ErbB signalling network

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.

Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells.

Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events.

P2888

s41598-017-14607-2

P304

14584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-14607-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29109513

http://www.w3.org/2001/XMLSchema#string

P932

5674043

http://www.w3.org/2001/XMLSchema#string

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer.

about

P2860

P2860

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932